Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 8, 2001, Pages

  Jones, Paul ^a   Greenstone, Michael ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR;

CARBON DIOXIDE TENSION; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HUMAN; HYPERCAPNIA; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG GAS EXCHANGE; METABOLIC ACIDOSIS; OXYGEN CONSUMPTION; OXYGEN TENSION; OXYGEN THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; REVIEW; SLEEP; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; VITAL CAPACITY; CLINICAL TRIAL; FEMALE; MALE;

ACETAZOLAMIDE; CARBONIC ANHYDRASE INHIBITORS; CLINICAL TRIALS; FEMALE; HUMANS; HYPERCAPNIA; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY;

EID: 84921440165     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002881     Document Type: Review

References (14)

1. Hacki M, Waldbeck G, Brandli O. Acetazolomide in hypercapnic chronic obstructive lung disease - a renaissance? [Acetazolomide bei hyperkapnischer chronischer obstruktiver Lungenkrankheit - eine Renaissance?]. Schweizerishce medizinische Wochenschift 1983;113(3):110-4. 3026654
2. Skatrud J, Dempsey J. Relative effectiveness of Acetazlomide versus medroxyprogesterone acetate in correction of chronic carbon dioxide retention. American Review of Respiratory Disease 1983;127(4):405-12. 3026656
3. Vos P, Folgering H, de Boo T, Lemmens W, van Herwaarden C. Effects of chloromadione acetate and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease. European Respiratory Journal 1994;7(5):850-5. 3026658
4. Wagenaar M, Vos P, Heijdra Y, Teppema L, Folgering H. Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD. Chest 2003;123(5):1450-9. 3026660
5. Wagenaar M, Vos P, Heijdra Y, van Herwaarden C, Folgering H. The effects of Medroxyprogesterone acetate and acetazolomide on the nocturnal oxygen saturation in COPD patients. [unpublished] 1999. 3026661
6. Chin R, Pesce R. Practical aspects in management of respiratory failure in chronic obstructive pulmonary disease. Critical Care Quarterly 1983;6(2):1-21. 3026663
7. DeBacker W, Verbraecken J, Willemen M, Wittsaele W, DeCock W, van de Hayning P. Central apnea index decreases after prolonged treatment with acetazolomide. American Journal of Respiratory and Critical Care Medicine 1995;151(1):87-91. 3026665
8. Izquierido J, Morera J. Respiratory stimulants and COPD [Estimulantes respiratorios y EPOC]. Revista Clinica Espanola 1994;194(12):1003-5. 3026667
9. Noone P, Olivier K, Knowles M. Modulation of the ionic milieu of the airway in health and disease. Annual Review of Medicine 1994;45:421-34. 3026669
10. Vos P, Folgering H, van Herwaarden C. Visual attention in patients with chronic obstructive pulmonary disease. Biological Psychology 1995;41(3):295-305. 3026671
11. Wagenaar M, Vos PJ, Heijdra YF, Teppema LJ, Folgering HT. Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients. European Respiratory Journal 2002;20(5):1130-7. 3026673
12. Faisy C, Meziani F, Planquette B, Clavel M, Gacouin A, Bornstain C, et al. Effect of acetazolamide vs placebo on duration of invasive mechanical ventilation among patients with chronic obstructive pulmonary disease: a randomized clinical trial. JAMA. United States: American Medical Association (E-mail: smcleod@itsa.ucsf.edu), 2016; Vol. 315, issue 5:480-8. 6614831
13. Fontana V, Santinelli S, Internullo M, Marinelli P, Sardo L, Alessandrini G, et al. Effect of acetazolamide on post-niv metabolic alkalosis in acute exacerbated COPD patients. European review for medical and pharmacological sciences. Italy, 2016; Vol. 20, issue 1:37-43. 6614833
14. Rialp Cervera G, Raurich Puigdevall JM, Moran Chorro I, Martin Delgado MC, Heras la Calle G, Mas Serra A, et al. Effects of early administration of acetazolamide on the duration of mechanical ventilation in patients with chronic obstructive pulmonary disease or obesity-hypoventilation syndrome with metabolic alkalosis. A randomized trial. Pulmonary pharmacology & therapeutics. England: Academic Press, 2017; Vol. 44:30-7. 6614835